Welcome to our dedicated page for Health Catalyst news (Ticker: HCAT), a resource for investors and traders seeking the latest updates and insights on Health Catalyst stock.
Health Catalyst, Inc. (Nasdaq: HCAT) is a leading provider of data and analytics technology and services to healthcare organizations. Founded by healthcare veterans, the company specializes in building comprehensive data warehousing and process improvement solutions, aiming to significantly enhance healthcare delivery. Health Catalyst's innovative solutions are powered by its adaptive data architecture, which uses a late-binding bus model for agile and quick implementation.
The company operates primarily through two segments: Technology and Professional Services. The Technology segment is the key revenue driver, providing data platforms, analytics applications, and support services under cloud-based subscriptions, time-based licenses, and maintenance agreements. The Professional Services segment offers analytics, implementation, strategic advisory, outsourcing, and improvement services, enabling clients to maximize the utility of Health Catalyst's technological offerings.
Health Catalyst has recently gained recognition with several achievements:
- VitalCDM: Ranked number one in the Revenue Cycle - Chargemaster Management category of the 2024 Best in KLAS: Software & Services.
- MeasureAble™: Achieved ONC-Health IT 2015 Edition Certification, allowing its use for various quality reporting programs.
- Able Health Registry: Received QPP Qualified Registry approval for the 2024 performance year from CMS.
- Acquisition of Carevive Systems: Strengthened their capabilities in oncology data analytics, improving patient care and outcomes.
Financially, Health Catalyst continues to show promising trends, with forward-looking revenue and EBITDA guidance indicating growth. The company frequently updates its investors through quarterly earnings calls and reports, reflecting transparency and financial health.
Health Catalyst envisions a future where all healthcare decisions are data-informed, leveraging a cloud-based data platform encompassing over 100 million patient records and trillions of data points. This commitment to data-informed decision-making is at the core of its mission to drive measurable improvements in clinical, financial, and operational metrics for healthcare organizations.
For more information, visit the Health Catalyst Investor Relations page.
Health Catalyst, a key player in data and analytics for healthcare, announced participation in the 41st Annual William Blair Growth Stock Conference on June 2, 2021, at 5:40 p.m. ET. CEO Dan Burton and SVP Adam Brown will engage in a fireside chat during the event. A webcast will be accessible via their investor relations page. Health Catalyst empowers healthcare organizations with cloud-based data platforms, utilizing insights from over 100 million patient records to enhance clinical, financial, and operational outcomes, ultimately striving for data-informed healthcare decisions.
Health Catalyst (Nasdaq: HCAT) reported a 24% increase in total revenue for Q1 2021, reaching $55.846 million compared to $45.116 million in Q1 2020. Technology revenue grew 37% to $33.839 million, while professional services revenue rose 8% to $22.007 million. Despite this growth, the company experienced a 62% increase in net loss, totaling $(28.370 million). Adjusted EBITDA improved by 86% to $(837,000). Employee satisfaction remains high, with scores in the 96th percentile. The company continues to navigate challenges from the pandemic while integrating new team members.
Health Catalyst, Inc. (Nasdaq: HCAT) will report its Q1 2021 operating results on May 6, 2021, after market close. The company also plans to host a conference call at 5 p.m. E.T. to discuss these results. Participants can access the call by dialing in or through a live audio webcast available on the company's investor relations website. The replay of the conference call will be accessible for approximately 90 days. Health Catalyst provides data and analytics technology aimed at improving healthcare outcomes.
Health Catalyst, Inc. (NASDAQ: HCAT) announced that its CEO, Dan Burton, was honored as "CEO of the Year 2021" by Utah Business. The recognition acknowledges leaders who exhibit strength and impact within their organizations. Under Burton's guidance, Health Catalyst evolved into a multibillion-dollar entity, achieving significant growth despite the pandemic. The company maintained its workforce, acquired three tech firms, and enhanced its product offerings, including nine COVID-specific capabilities. Since its IPO in July 2019, Health Catalyst has consistently ranked high in employee engagement metrics.
Health Catalyst launched Healthcare.AI, a suite of AI products and services aimed at addressing challenges in revenue, cost, and quality within healthcare organizations. The suite expands AI use cases, featuring five levels of analytics. It allows easy integration into existing tools and significantly reduces the time required to deliver analytical insights from months to minutes. Expert services support organizations in tailoring predictive models. This innovation aims to improve decision-making across various healthcare settings, addressing the industry's evolving challenges.
SOUTH JORDAN, Utah, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Health Catalyst (Nasdaq: HCAT) announced participation in upcoming investor conferences. Bryan Hunt, CFO, and Adam Brown, SVP of Investor Relations, will present at the Raymond James & Associates’ 42nd Annual Institutional Investors Conference on March 3, 2021, with a fireside chat at 12:30 p.m. EST. They will also participate in the 2021 Truist Securities Technology, Internet & Services Conference on March 9, 2021. Health Catalyst provides data and analytics technology to healthcare organizations to improve clinical, financial, and operational outcomes.
Health Catalyst (HCAT) reported its 2020 financial results, showcasing a 22% increase in total revenue, reaching $188.8 million. Technology revenue surged 32% year-over-year, driven by strong demand for data analytics amid the pandemic. Despite revenue growth, net losses ballooned by 202% to $43 million due to increased operational expenses. The company maintained a 102% dollar-based retention rate for its technology services, although professional services retention declined. Health Catalyst is optimistic about future growth, considering its robust technology usage during the health crisis.
Transformation Capital, a leader in digital health investments, announced the hiring of Jenna Ciotti as Vice President and Akhi Samant as Associate. Jenna, with experience at M33 Growth, will drive deal sourcing in digital health. She holds degrees from Yale University and focuses on improving health outcomes. Akhi, formerly at Goldman Sachs, brings expertise in technology and finance. Their addition aligns with Transformation's growth strategy and commitment to supporting innovative healthcare solutions, enhancing its impactful portfolio that includes notable companies like Health Catalyst (NASDAQ: HCAT).
Health Catalyst (HCAT) has partnered with Smarter Health, a Singapore-based healthcare technology company, to enhance data integration between payors and providers in Southeast Asia. This collaboration aims to address inefficiencies in medical billing and claims administration, leveraging Health Catalyst's Data Operating System and analytics capabilities. The partnership will facilitate improved transparency, service, and satisfaction within the healthcare ecosystem, ultimately supporting payors in evaluating care appropriateness and cost.
Health Catalyst (Nasdaq: HCAT) will announce its fourth quarter and full year 2020 operating results on February 25, 2021, after market close. A conference call will be held at 5 p.m. E.T. on the same day to discuss the results. The call can be accessed by U.S. participants at 1-877-295-1104 or 1-470-495-9486 internationally, using participant code 3180522. An online audio webcast will also be available. Health Catalyst specializes in data and analytics technology for healthcare, aiming for data-informed healthcare decisions.
FAQ
What is the current stock price of Health Catalyst (HCAT)?
What is the market cap of Health Catalyst (HCAT)?
What does Health Catalyst, Inc. do?
What are the main segments of Health Catalyst's business?
What recent achievements has Health Catalyst made?
What is the adaptive data architecture?
How does Health Catalyst generate its revenue?
What is the Best in KLAS ranking?
What is the significance of the MeasureAble™ ONC-Health IT certification?
How does the acquisition of Carevive Systems benefit Health Catalyst?
How does Health Catalyst support its clients?
Where can I find more information about Health Catalyst's financial performance?
